Tandem Diabetes (TNDM) Misses Q3 EPS by 3c

Tandem Diabetes (NASDAQ: TNDM) reported Q3 EPS of ($0.51), $0.03 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $185.6 million versus the consensus estimate of $192.89 million.

For earnings history and earnings-related data on Tandem Diabetes (TNDM) click here.

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• BofA maintains underperform ratings on six BDC stocks
• Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions